{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:49:49Z","timestamp":1779317389318,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"am","delay-in-days":306,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","award":["W81XWH-16-1-0691"],"award-info":[{"award-number":["W81XWH-16-1-0691"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","award":[".141103"],"award-info":[{"award-number":[".141103"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejmech.2018.11.065","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T04:38:55Z","timestamp":1543379935000},"page":"256-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridines"],"prefix":"10.1016","volume":"163","author":[{"given":"Randy","family":"Wouters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szu-Yuan","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathy","family":"Froeyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eveline","family":"Lescrinier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirit","family":"Einav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet","family":"Herdewijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3872-6558","authenticated-orcid":false,"given":"Steven","family":"De Jonghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.11.065_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-337-0_1","article-title":"Targeting cancer with small-molecular-weight kinase inhibitors","volume":"795","author":"Fabbro","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2018.11.065_bib2","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.8b00667","article-title":"Kinase inhibitors for the treatment of immunological disorders: recent advances","author":"Bryan","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.065_bib3","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bmcl.2018.05.007","article-title":"Brain penetrant kinase inhibitors: learning from kinase neuroscience discovery","volume":"28","author":"Shi","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.11.065_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jb\/mvv069","article-title":"Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside","volume":"158","author":"Tanaka","year":"2015","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.ejmech.2018.11.065_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/dna.2017.4033","article-title":"Repurposing of kinase inhibitors as broad-spectrum antiviral drugs","volume":"37","author":"Schor","year":"2018","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.ejmech.2018.11.065_bib6","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/AAC.01175-13","article-title":"A\u00a0novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase III\u03b2","volume":"57","author":"van der Schaar","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.11.065_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.antiviral.2017.03.024","article-title":"The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in\u00a0vitro and provides a prolonged treatment window compared to standard of care in\u00a0vivo","volume":"142","author":"Haasbach","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2018.11.065_bib8","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1128\/JVI.01134-16","article-title":"High-Throughput small interfering RNA screening identifies phosphatidylinositol 3-kinase class II alpha as important for production of human cytomegalovirus virions","volume":"90","author":"Polachek","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2018.11.065_bib9","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/hep.29236","article-title":"Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication","volume":"66","author":"Diab","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2018.11.065_bib10","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1007\/s00018-018-2882-0","article-title":"Viral journeys on the intracellular highways","volume":"75","author":"Robinson","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2018.11.065_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm3151","article-title":"Molecular mechanism and physiological functions of clathrin-mediated endocytosis","volume":"12","author":"McMahon","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.11.065_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrm1786","article-title":"Life of a clathrin coat: insights from clathrin and AP structures","volume":"7","author":"Edeling","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.11.065_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1083\/jcb.200111068","article-title":"Phosphorylation of the AP2 \u03bc subunit by AAK1 mediates high affinity binding to membrane protein sorting signals","volume":"156","author":"Ricotta","year":"2002","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ejmech.2018.11.065_bib14","doi-asserted-by":"crossref","first-page":"10296","DOI":"10.1073\/pnas.0403175101","article-title":"The serine\/threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling","volume":"101","author":"Zhang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2018.11.065_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1083\/jcb.200211080","article-title":"AP-1 binding to sorting signals and release from clathrin-coated vesicles is regulated by phosphorylation","volume":"160","author":"Ghosh","year":"2003","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ejmech.2018.11.065_bib16","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1242\/jcs.02548","article-title":"Depletion of GAK\/auxilin 2 inhibits receptor-mediated endocytosis and recruitment of both clathrin and clathrin adaptors","volume":"118","author":"Lee","year":"2005","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ejmech.2018.11.065_bib17","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1016\/S0960-9822(01)00010-0","article-title":"Clathrin uncoating: auxilin comes to life","volume":"11","author":"Lemmon","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejmech.2018.11.065_bib18","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1128\/JVI.02705-14","article-title":"AP-2-Associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets","volume":"89","author":"Neveu","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2018.11.065_bib19","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1172\/JCI89857","article-title":"Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects","volume":"127","author":"Bekerman","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2018.11.065_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02233-17","article-title":"Interactions between the hepatitis C virus nonstructural 2 protein and host adaptor proteins 1 and 4 orchestrate virus release","volume":"9","author":"Xiao","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2018.11.065_bib21","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1021\/acs.jmedchem.8b00613","article-title":"Optimization of isothiazolo[4,3- b ]pyridine-Based inhibitors of cyclin G associated kinase (GAK) with broad-spectrum antiviral activity","volume":"61","author":"Pu","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.065_bib22","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1021\/jm501759m","article-title":"Selective inhibitors of cyclin G associated kinase (GAK) as anti- hepatitis C agents","volume":"58","author":"Kovackova","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.065_bib23","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1039\/C5MD00229J","article-title":"Isothiazolo[4,3-b]pyridines as inhibitors of cyclin G associated kinase: synthesis, structure\u2013activity relationship studies and antiviral activity","volume":"6","author":"Li","year":"2015","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2018.11.065_bib24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1039\/j19680000561","article-title":"Reactions of tris(triphenylphosphine)platinum(o) and tetrakis(triphenylphosphine)palladium(o) with oxygen and carbon dioxide","volume":"0","author":"Nyman","year":"1968","journal-title":"J.\u00a0Chem. Soc. A Inorganic, Phys. Theor."},{"key":"10.1016\/j.ejmech.2018.11.065_bib25","doi-asserted-by":"crossref","first-page":"11408","DOI":"10.1021\/jp800205j","article-title":"Isomerization and hydrogenation of cis -2-Butene on Pd model catalyst","volume":"112","author":"Brandt","year":"2008","journal-title":"J.\u00a0Phys. Chem. C"},{"key":"10.1016\/j.ejmech.2018.11.065_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0021-9517(74)90085-2","article-title":"Mechanism of heterogeneous catalytic cis-trans isomerization and double-bond migration of octadecenoates","volume":"32","author":"Heertje","year":"1974","journal-title":"J.\u00a0Catal."},{"key":"10.1016\/j.ejmech.2018.11.065_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nbt1068","article-title":"A\u00a0small molecule\u2013kinase interaction map for clinical kinase inhibitors","volume":"23","author":"Fabian","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2018.11.065_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.antiviral.2018.05.001","article-title":"Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment","volume":"155","author":"Pu","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2018.11.065_bib29","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1128\/JVI.02424-12","article-title":"Membrane topology and function of dengue virus NS2A protein","volume":"87","author":"Xie","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2018.11.065_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.antiviral.2011.05.001","article-title":"Development and characterization of a stable luciferase dengue virus for high-throughput screening","volume":"91","author":"Zou","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2018.11.065_bib31","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2018.11.065_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418310249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418310249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:48:59Z","timestamp":1759326539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418310249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":32,"alternative-id":["S0223523418310249"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.065","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridines","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}